Skip to content
SiNON

SiNON

THERAPEUTICS

SiNON

close
  • Home
  • About Us
  • Team
  • Research
  • Collaborations
  • News
  • Contact Us

News

  • Home
  • News
1. Changing The Way We Treat Neurological Diseases
2. RTP Startup Advances To National innovateHER Pitch
3. SiNON Therapeutics Creates A Trojan Horse For Pharma
4. CED Life Science Conference 2017
Video SiNON is dedicated to improving the lives of those who suffer from debilitating neurological diseases by increasing the ability of drugs to cross the Blood Brain Barrier (BBB). Our patented nanoparticle, the Carbon Dot, will enable pharmaceutical companies to encapsulate their drugs in a way which dramatically improves drug-localization to the brain. This allows for a reduction in overall dose administration to the patient, leading to reduced toxicity risk and side-effects while improving therapeutic index and cost-efficacy. Considering the rapid growth of the senior population, and subsequent increase in neurological disease, we believe that our novel technology is an essential part of the overall solution to this healthcare crisis in the US and around the world.
5. Publications
6. Carbon Nano Onions Cross The Blood Brain Barrier
7. SiNON Among 50 Companies Selected For CED Conference
8. BRC D2D Interview
Video SiNON is dedicated to improving the lives of those who suffer from debilitating neurological diseases by increasing the ability of drugs to cross the Blood Brain Barrier (BBB). Our patented nanoparticle, the Carbon Dot, will enable pharmaceutical companies to encapsulate their drugs in a way which dramatically improves drug-localization to the brain. This allows for a reduction in overall dose administration to the patient, leading to reduced toxicity risk and side-effects while improving therapeutic index and cost-efficacy. Considering the rapid growth of the senior population, and subsequent increase in neurological disease, we believe that our novel technology is an essential part of the overall solution to this healthcare crisis in the US and around the world.
9. SiNON Overcomes Barriers To Win Grand Prize
SiNON is dedicated to improving the lives of those who suffer from debilitating neurological diseases by increasing the ability of drugs to cross the Blood Brain Barrier (BBB). Our patented nanoparticle, the Carbon Dot, will enable pharmaceutical companies to encapsulate their drugs in a way which dramatically improves drug-localization to the brain. This allows for a reduction in overall dose administration to the patient, leading to reduced toxicity risk and side-effects while improving therapeutic index and cost-efficacy. Considering the rapid growth of the senior population, and subsequent increase in neurological disease, we believe that our novel technology is an essential part of the overall solution to this healthcare crisis in the US and around the world.
10. SiNON Wins The 16th Annual Duke Startup Challenge – Entrepreneurship Week 2015
Copyright © 2023 SiNON. All rights reserved. Theme Suffice by ThemeGrill. Powered by: WordPress.
  • Support
  • FAQs

SiNON

close
  • Home
  • About Us
  • Team
  • Research
  • Collaborations
  • News
  • Contact Us